BIZZARI JEAN-PIERRE
SEC CIK 1630914 · EDGAR
BoughtSold
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 19:04 | 2026-06-16 | APRE | Aprea Therapeutics, Inc. | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +3,135 | 4,180 | +300% | $0 |
| 2026-06-03 17:02 | 2026-06-01 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +45.0K | 151.9K | +42% | $0 | |
| 2026-06-03 17:02 | 2026-06-03 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | F - Tax | $3.08 | -12.6K | 139.3K | -8% | -$38.8K | |
| 2025-06-17 | 2025-06-13 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | F - Tax | $3.58 | -12.6K | 106.9K | -11% | -$45.1K | |
| D | 2025-06-09 | 2025-06-05 | APRE | Aprea Therapeutics, Inc. | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +1,045 | 1,045 | New | $0 |
| 2025-06-05 | 2025-06-03 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +40.0K | 119.5K | +50% | $0 | |
| 2024-06-18 | 2024-06-17 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | S - Sale | $2.89 | -6,995 | 79.5K | -8% | -$20.2K | |
| 2024-06-14 | 2024-06-13 | ADCT | ADC Therapeutics SA | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +40.0K | 86.5K | +86% | $0 | |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +8,065 | 66.8K | +14% | $0 |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +6,206 | 58.8K | +12% | $0 | |
| 2021-08-25 | 2021-08-25 | HALO | HALOZYME THERAPEUTICS, INC. | BIZZARI JEAN-PIERRE | Dir | S - Sale | $41.01 | -35.0K | 52.5K | -40% | -$1.44M |
Purchase Sale Sale after option exercise All abbreviations